Article Details

Ninth Circuit strengthens FDA authority to enforce drug regs against certain stem cell products

Retrieved on: 2024-10-02 19:02:22

Tags for this article:

Click the tags to see associated articles and topics

Ninth Circuit strengthens FDA authority to enforce drug regs against certain stem cell products. View article details on hiswai:

Summary

The article outlines legal challenges in regulating regenerative medicine, highlighting FDA oversight on stem cell products like SVF under U.S. law. The Ninth Circuit's decision aligns with FDA standards, impacting stem-cell therapy practices.

Article found on: www.jdsupra.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up